JP2023527315A5 - - Google Patents

Info

Publication number
JP2023527315A5
JP2023527315A5 JP2022571280A JP2022571280A JP2023527315A5 JP 2023527315 A5 JP2023527315 A5 JP 2023527315A5 JP 2022571280 A JP2022571280 A JP 2022571280A JP 2022571280 A JP2022571280 A JP 2022571280A JP 2023527315 A5 JP2023527315 A5 JP 2023527315A5
Authority
JP
Japan
Prior art keywords
alkyl
heterocycline
nitrogen
group
monocyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2022571280A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023527315A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/033159 external-priority patent/WO2021236771A1/en
Publication of JP2023527315A publication Critical patent/JP2023527315A/ja
Publication of JP2023527315A5 publication Critical patent/JP2023527315A5/ja
Ceased legal-status Critical Current

Links

JP2022571280A 2020-05-22 2021-05-19 Pd-l1を標的とするための方法及び組成物 Ceased JP2023527315A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063028882P 2020-05-22 2020-05-22
US63/028,882 2020-05-22
US202163159075P 2021-03-10 2021-03-10
US63/159,075 2021-03-10
PCT/US2021/033159 WO2021236771A1 (en) 2020-05-22 2021-05-19 Methods and compositions for targeting pd-l1

Publications (2)

Publication Number Publication Date
JP2023527315A JP2023527315A (ja) 2023-06-28
JP2023527315A5 true JP2023527315A5 (cg-RX-API-DMAC7.html) 2024-05-27

Family

ID=78708022

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022571280A Ceased JP2023527315A (ja) 2020-05-22 2021-05-19 Pd-l1を標的とするための方法及び組成物

Country Status (9)

Country Link
US (1) US11760764B2 (cg-RX-API-DMAC7.html)
EP (1) EP4153567A4 (cg-RX-API-DMAC7.html)
JP (1) JP2023527315A (cg-RX-API-DMAC7.html)
KR (1) KR20230030056A (cg-RX-API-DMAC7.html)
CN (1) CN115835907A (cg-RX-API-DMAC7.html)
AU (1) AU2021275118A1 (cg-RX-API-DMAC7.html)
CA (1) CA3182131A1 (cg-RX-API-DMAC7.html)
TW (1) TW202208320A (cg-RX-API-DMAC7.html)
WO (1) WO2021236771A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3182595A1 (en) 2020-06-17 2021-12-23 Mingming Zhang Immunosuppressant, and preparation method therefor and use thereof
JP2023539463A (ja) 2020-08-17 2023-09-14 アリゴス セラピューティクス インコーポレイテッド Pd-l1を標的とするための方法及び組成物
EP4337202A4 (en) 2021-06-18 2025-04-02 Aligos Therapeutics, Inc. METHODS AND COMPOSITIONS FOR TARGETING PD-L1
US20250340529A1 (en) * 2021-07-02 2025-11-06 Ascletis BioScience Co., Ltd Heterocyclic Compounds as Immunomodulators of PD-L1 Interactions
AU2022306289A1 (en) 2021-07-09 2024-01-18 Aligos Therapeutics, Inc. Anti-viral compounds
EP4387974A1 (en) * 2021-08-17 2024-06-26 Ascletics Bioscience Co., Ltd. Compounds as immunomodulators of pd-l1 interactions
WO2023043816A1 (en) 2021-09-17 2023-03-23 Aligos Therapeutics, Inc. Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections
EP4448512A4 (en) 2021-12-16 2025-11-19 Aligos Therapeutics Inc METHODS AND COMPOSITIONS FOR TARGETING PD-L1
EP4556465A4 (en) * 2022-11-22 2025-10-29 Xian Xintong Pharmaceutical Res Co Ltd NEW BICYCLIC PD-L1 INHIBITORS, THEIR PREPARATION PROCESSES AND MEDICINAL USES
WO2025015063A1 (en) * 2023-07-13 2025-01-16 Aligos Therapeutics, Inc. Methods and compositions for targeting pd-l1
WO2025174835A1 (en) * 2024-02-15 2025-08-21 Aligos Therapeutics, Inc. Methods and compositions for targeting pd-l1
WO2025199273A1 (en) * 2024-03-22 2025-09-25 Aligos Therapeutics, Inc. Methods and compositions for targeting pd-l1
WO2025199281A1 (en) * 2024-03-22 2025-09-25 Aligos Therapeutics, Inc. Methods and compositions for targeting pd-l1

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5359084A (en) 1993-02-18 1994-10-25 General Electric Company Method of preparing aromatic ether bisimides
ATE323076T1 (de) 2000-08-08 2006-04-15 Ortho Mcneil Pharm Inc Bicyclische verbindungen als h3 rezeptor liganden
DE10104279A1 (de) 2001-01-31 2002-08-01 Heinz Langhals Kompetitive Prionen-Reagenzien und ihre Anwendung in Diagnostik und Therapie
US7973060B2 (en) 2005-10-13 2011-07-05 Crystalgenomics, Inc. Fab I inhibitor and process for preparing same
US20080186971A1 (en) 2007-02-02 2008-08-07 Tarari, Inc. Systems and methods for processing access control lists (acls) in network switches using regular expression matching logic
KR101462535B1 (ko) 2007-10-15 2014-11-19 삼성디스플레이 주식회사 인덴 유도체 화합물 및 이를 이용한 유기 발광 소자
CA2750577A1 (en) 2008-12-03 2010-06-10 Presidio Pharmaceuticals, Inc. Inhibitors of hcv ns5a
US20120040977A1 (en) 2009-02-23 2012-02-16 Presidio Pharmaceuticals, Inc. Inhibitors of hcv ns5a
KR101382019B1 (ko) 2009-05-11 2014-04-04 다이니치 세이카 고교 가부시키가이샤 유기 반도체 재료, 유기 반도체 박막 및 유기 박막 트랜지스터
JP5765229B2 (ja) 2009-10-05 2015-08-19 和光純薬工業株式会社 新規重水素化方法
WO2011082400A2 (en) * 2010-01-04 2011-07-07 President And Fellows Of Harvard College Modulators of immunoinhibitory receptor pd-1, and methods of use thereof
KR101832171B1 (ko) 2010-10-25 2018-04-16 삼성디스플레이 주식회사 축합환 화합물, 이를 포함한 유기 발광 소자 및 상기 유기 발광 소자를 포함한 평판 표시 장치
JP5728921B2 (ja) 2010-12-10 2015-06-03 コニカミノルタ株式会社 光学フィルム、及びそれを用いた偏光板、液晶表示装置
US9464065B2 (en) 2011-03-24 2016-10-11 The Scripps Research Institute Compounds and methods for inducing chondrogenesis
ITMI20110881A1 (it) 2011-05-18 2012-11-19 E T C Srl Materiale semiconduttore organico
EP3108519B1 (de) 2014-02-20 2018-06-20 InnovationLab GmbH Konjugierte polymere
KR20160001537A (ko) 2014-06-27 2016-01-06 희성소재 (주) 피라졸계 화합물 및 이를 이용한 유기발광소자
WO2016046300A1 (en) 2014-09-24 2016-03-31 Solvay Specialty Polymers Italy S.P.A. Fluoropolymer composition
CN104478900B (zh) 2014-12-02 2017-05-31 国家纳米科学中心 一种内酰胺类受体单元及其制备方法和用途
JP2019530732A (ja) 2016-08-03 2019-10-24 アライジング・インターナショナル・インコーポレイテッドArising International, Inc. 免疫モジュレータとして有用な対称または半対称化合物
KR20180063710A (ko) 2016-12-02 2018-06-12 (주)피엔에이치테크 유기발광 화합물 및 이를 포함하는 유기전계발광소자
JP7101678B2 (ja) * 2016-12-22 2022-07-15 インサイト・コーポレイション 免疫調節剤としての複素環式化合物
WO2018119263A1 (en) 2016-12-22 2018-06-28 Incyte Corporation Heterocyclic compounds derivatives as pd-l1 internalization inducers
ES2874756T3 (es) * 2016-12-22 2021-11-05 Incyte Corp Derivados de triazolo[1,5-A]piridina como inmunomoduladores
LT3558990T (lt) * 2016-12-22 2022-12-27 Incyte Corporation Tetrahidroimidazo[4,5-c]piridino dariniai kaip pd-l1 internalizavimo induktoriai
EP3381906A1 (en) 2017-03-27 2018-10-03 Leadiant Biosciences SA Compounds for use as heparanase inhibitors
BR102018007822A2 (pt) * 2017-04-20 2018-11-06 Gilead Sciences, Inc. composto, métodos para inibir pd-1, pd-l1 e/ou interação de pd-1/pd-l1 e para tratamento de câncer, composição farmacêutica, e, kit para tratamento de ou prevenção de câncer ou uma doença ou condição
KR102629376B1 (ko) 2017-10-04 2024-01-25 가부시키가이샤 아데카 조성물, 경화물 및 경화물의 제조 방법
CN118994041A (zh) 2017-10-05 2024-11-22 株式会社艾迪科 化合物、潜在性紫外线吸收剂、组合物、固化物及固化物的制造方法
CN107721805A (zh) 2017-11-08 2018-02-23 长春海谱润斯科技有限公司 一种有机电致发光材料及其有机发光器件
TWI712412B (zh) * 2018-04-19 2020-12-11 美商基利科學股份有限公司 Pd‐1/pd‐l1抑制劑
KR102793841B1 (ko) 2018-05-08 2025-04-11 가부시키가이샤 아데카 화합물, 잠재성 첨가제, 조성물, 경화물, 경화물의 제조 방법 및 조성물의 제조 방법
CN112424185B (zh) 2018-07-13 2024-05-17 广州丹康医药生物有限公司 含苯环的化合物、其制备方法及应用
CN111039942B (zh) * 2018-10-12 2023-04-14 上海长森药业有限公司 含氮杂环类化合物,及其制备方法、药物组合物和应用
WO2020126970A1 (en) 2018-12-19 2020-06-25 Solvay Specialty Polymers Usa, Llc Method for manufacturing a three-dimensional object
DE102019200805A1 (de) 2019-01-23 2020-07-23 Henkel Ag & Co. Kgaa Neue fluoreszierende Materialien auf Basis von Phthalimiden
CN111574504A (zh) 2019-02-19 2020-08-25 江苏三月光电科技有限公司 一种基于氮杂苯和二甲酰二胺衍生物的有机化合物及其应用
WO2020210831A1 (en) 2019-04-12 2020-10-15 TONIX Pharmaceuticals Holding Corp Inhibitors of cd40-cd154 binding
WO2020211822A1 (zh) 2019-04-18 2020-10-22 成都海创药业有限公司 一类靶向降解雄激素受体的双功能嵌合体杂环化合物及其用途
WO2020257549A2 (en) 2019-06-20 2020-12-24 Chemocentryx, Inc. Compounds for treatment of pd-l1 diseases
CN110746344A (zh) 2019-11-19 2020-02-04 上海天马有机发光显示技术有限公司 一种化合物及其应用
JP2023539463A (ja) 2020-08-17 2023-09-14 アリゴス セラピューティクス インコーポレイテッド Pd-l1を標的とするための方法及び組成物
EP4337202A4 (en) 2021-06-18 2025-04-02 Aligos Therapeutics, Inc. METHODS AND COMPOSITIONS FOR TARGETING PD-L1

Similar Documents

Publication Publication Date Title
JP2023527315A5 (cg-RX-API-DMAC7.html)
RU2350605C2 (ru) Аналоги хиназолина в качестве ингибиторов рецепторных тирозинкиназ
RU2486181C2 (ru) Пиримидилциклопентаны как ингибиторы акт-протеинкиназ
FI3932919T3 (fi) Jak-inhibiittoriyhdiste ja sen käyttö
JP5865519B2 (ja) イミダゾピロリジノン化合物
JP2011509309A5 (cg-RX-API-DMAC7.html)
JP2020515575A5 (cg-RX-API-DMAC7.html)
JP2013506715A5 (cg-RX-API-DMAC7.html)
JP2012532131A5 (cg-RX-API-DMAC7.html)
JP2007534687A5 (cg-RX-API-DMAC7.html)
JP2011507854A5 (cg-RX-API-DMAC7.html)
JP2013544893A5 (cg-RX-API-DMAC7.html)
JP2018526413A5 (cg-RX-API-DMAC7.html)
CA2473026A1 (en) 2-(pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones
JP2017535561A5 (cg-RX-API-DMAC7.html)
JP2021514400A5 (cg-RX-API-DMAC7.html)
CA2577937A1 (en) Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors
CA2667392A1 (en) Substituted dihydropyrazolones and use thereof as hif-prolyl-4 -hydroxylase inhibitors
KR20160013028A (ko) 키나제 조정을 위한 화합물 및 그에 대한 적응증
CA2743536A1 (en) Heterocyclically substituted aryl compounds as hif inhibitors
JP2016518437A5 (cg-RX-API-DMAC7.html)
JP2011509937A5 (cg-RX-API-DMAC7.html)
JP2013543883A5 (cg-RX-API-DMAC7.html)
JP2005514398A5 (cg-RX-API-DMAC7.html)
CA2749040A1 (en) Triazolo and tetrazolo pyrimidine derivatives as hne inhibitors for treating copd